CEO Sean Saint and CFO Stephen Feider spoke about what’s different now that the company is public and the long journey of ...

The maker of patient monitoring devices said the incident will not have a material effect on its updated financial outlook.

IPO drought, the industry is questioning whether the window for medtech public offerings is open following a small burst of ...

The company also shared more details of its exit from the TAVR market and the impact of FDA layoffs on product review times.

The Court of International Trade said the president overstepped his authority, halting various duties. After an appeal, the ...

Boston Scientific said it would halt worldwide sales of its Acurate devices due to “increased clinical and regulatory ...

Thornal will join the orthopedics company as group president for global businesses and the Americas, a newly created position ...

A problem when preparing the devices for use can delay diagnosis or treatment, leading BD to update its instructions.

The duties are slated to take effect July 9 as the bloc and the U.S. reengage on trade talks, the president said.

The company will compete with a device Boston Scientific acquired for $850 million.

Speaker Mike Johnson negotiated a number of last minute changes to the megabill to get it across the finish line, including ...

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...